 | • レポートコード：20QY06-02598 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ナルコレプシー薬のグローバル市場について種類別（酸化防止剤タイプ、興奮剤タイプ、その他）、用途別（日中の極度の眠気、カタプレキシア、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ナルコレプシー薬市場の概要 ・世界の主要地域別ナルコレプシー薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のナルコレプシー薬市場規模2015-2026：種類別（酸化防止剤タイプ、興奮剤タイプ、その他） ・世界のナルコレプシー薬市場規模2015-2026：用途別（日中の極度の眠気、カタプレキシア、その他） ・ナルコレプシー薬の北米市場規模2015-2020 ・ナルコレプシー薬のヨーロッパ市場規模2015-2020 ・ナルコレプシー薬の中国市場規模2015-2020 ・ナルコレプシー薬の日本市場規模2015-2020 ・ナルコレプシー薬の東南アジア市場規模2015-2020 ・ナルコレプシー薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jazz Pharmaceuticals、Teva Pharmaceutical、Novartis、Mylan） ・ナルコレプシー薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナルコレプシー薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Narcolepsy Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Narcolepsy Drug market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Narcolepsy Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Narcolepsy Drug industry.
Based on our recent survey, we have several different scenarios about the Narcolepsy Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2255.9 million in 2019. The market size of Narcolepsy Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Narcolepsy Drug market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Narcolepsy Drug market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Narcolepsy Drug market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Narcolepsy Drug market. The report also includes nautical information, where it shows Narcolepsy Drug market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Narcolepsy Drug market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Narcolepsy Drug market.
The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Geographical Analysis:
Based on region, the global Narcolepsy Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Narcolepsy Drug market are
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
…
Segment by Type
Antioxidants Type
Stimulants Type
Other
Segment by Application
Daytime Extreme Sleepiness
Cataplexia
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Narcolepsy Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Narcolepsy Drug market.
• The market share of the global Narcolepsy Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Narcolepsy Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Narcolepsy Drug market.
1 Narcolepsy Drug Market Overview
1.1 Narcolepsy Drug Product Scope
1.2 Narcolepsy Drug Segment by Type
1.2.1 Global Narcolepsy Drug Sales by Type (2020-2026)
1.2.2 Antioxidants Type
1.2.3 Stimulants Type
1.2.4 Other
1.3 Narcolepsy Drug Segment by Application
1.3.1 Global Narcolepsy Drug Sales Comparison by Application (2020-2026)
1.3.2 Daytime Extreme Sleepiness
1.3.3 Cataplexia
1.3.4 Others
1.4 Narcolepsy Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Narcolepsy Drug Sales Growth Rate (2015-2026)
1.4.2 Global Narcolepsy Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Narcolepsy Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Narcolepsy Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Narcolepsy Drug Industry
1.5.1.1 Narcolepsy Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Narcolepsy Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Narcolepsy Drug Players to Combat Covid-19 Impact
2 Narcolepsy Drug Estimate and Forecast by Region
2.1 Global Narcolepsy Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Narcolepsy Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Narcolepsy Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Narcolepsy Drug Revenue Market Share by Region (2015-2020)
2.3 Global Narcolepsy Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Narcolepsy Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Narcolepsy Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Narcolepsy Drug Estimates and Projections (2015-2026)
2.4.2 Europe Narcolepsy Drug Estimates and Projections (2015-2026)
2.4.3 China Narcolepsy Drug Estimates and Projections (2015-2026)
2.4.4 Japan Narcolepsy Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Narcolepsy Drug Estimates and Projections (2015-2026)
2.4.6 India Narcolepsy Drug Estimates and Projections (2015-2026)
3 Global Narcolepsy Drug Competition Landscape by Players
3.1 Global Top Narcolepsy Drug Players by Sales (2015-2020)
3.2 Global Top Narcolepsy Drug Players by Revenue (2015-2020)
3.3 Global Narcolepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Drug as of 2019)
3.4 Global Narcolepsy Drug Average Price by Company (2015-2020)
3.5 Manufacturers Narcolepsy Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Narcolepsy Drug Players (Opinion Leaders)
4 Global Narcolepsy Drug Market Size by Type
4.1 Global Narcolepsy Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Narcolepsy Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Narcolepsy Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Narcolepsy Drug Price by Type (2014-2020)
4.2 Global Narcolepsy Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Narcolepsy Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Narcolepsy Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Narcolepsy Drug Price Forecast by Type (2021-2026)
5 Global Narcolepsy Drug Market Size by Application
5.1 Global Narcolepsy Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Narcolepsy Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Narcolepsy Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Narcolepsy Drug Price by Application (2015-2020)
5.2 Global Narcolepsy Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Narcolepsy Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Narcolepsy Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Narcolepsy Drug Price Forecast by Application (2021-2026)
3 North America Narcolepsy Drug Market Facts & Figures
3.2 North America Narcolepsy Drug Sales Market Share by Company (2015-2020)
3.3 North America Narcolepsy Drug Sales Market Share by Type (2015-2020)
3.4 North America Narcolepsy Drug Sales Market Share by Application (2015-2020)
4 Europe Narcolepsy Drug Market Facts & Figures
4.2 Europe Narcolepsy Drug Sales Market Share by Company (2015-2020)
4.3 Europe Narcolepsy Drug Sales Market Share by Type (2015-2020)
4.4 Europe Narcolepsy Drug Sales Market Share by Application (2015-2020)
5 China Narcolepsy Drug Market Facts & Figures
5.2 China Narcolepsy Drug Sales Market Share by Company (2015-2020)
5.3 China Narcolepsy Drug Sales Market Share by Type (2015-2020)
5.4 China Narcolepsy Drug Sales Market Share by Application (2015-2020)
6 Japan Narcolepsy Drug Market Facts & Figures
6.2 Japan Narcolepsy Drug Sales Market Share by Company (2015-2020)
6.3 Japan Narcolepsy Drug Sales Market Share by Type (2015-2020)
6.4 Japan Narcolepsy Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Narcolepsy Drug Market Facts & Figures
7.2 Southeast Asia Narcolepsy Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Narcolepsy Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Narcolepsy Drug Sales Market Share by Application (2015-2020)
8 India Narcolepsy Drug Market Facts & Figures
8.2 India Narcolepsy Drug Sales Market Share by Company (2015-2020)
8.3 India Narcolepsy Drug Sales Market Share by Type (2015-2020)
8.4 India Narcolepsy Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Narcolepsy Drug Business
12.1 Jazz Pharmaceuticals
12.1.1 Jazz Pharmaceuticals Narcolepsy Drug Corporation Information
12.1.2 Jazz Pharmaceuticals Narcolepsy Drug Business Overview and Total Revenue
12.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Jazz Pharmaceuticals Narcolepsy Drug Products Offered
12.1.5 Jazz Pharmaceuticals Recent Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical Narcolepsy Drug Corporation Information
12.2.2 Teva Pharmaceutical Narcolepsy Drug Business Overview and Total Revenue
12.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceutical Narcolepsy Drug Products Offered
12.2.5 Teva Pharmaceutical Recent Development
12.3 Novartis
12.3.1 Novartis Narcolepsy Drug Corporation Information
12.3.2 Novartis Narcolepsy Drug Business Overview and Total Revenue
12.3.3 Novartis Narcolepsy Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Narcolepsy Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Mylan
12.4.1 Mylan Narcolepsy Drug Corporation Information
12.4.2 Mylan Narcolepsy Drug Business Overview and Total Revenue
12.4.3 Mylan Narcolepsy Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Narcolepsy Drug Products Offered
12.4.5 Mylan Recent Development
…
13 Narcolepsy Drug Manufacturing Cost Analysis
13.1 Narcolepsy Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Narcolepsy Drug
13.4 Narcolepsy Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Narcolepsy Drug Distributors List
14.3 Narcolepsy Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Narcolepsy Drug Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Narcolepsy Drug Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Narcolepsy Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Narcolepsy Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Narcolepsy Drug Players to Combat Covid-19 Impact
Table 8. Global Market Narcolepsy Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Narcolepsy Drug Sales (MT) by Region (2015-2020)
Table 10. Global Narcolepsy Drug Sales Market Share by Region (2015-2020)
Table 11. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Narcolepsy Drug Revenue Share by Region (2015-2020)
Table 13. Global Narcolepsy Drug Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Narcolepsy Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Narcolepsy Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Narcolepsy Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Narcolepsy Drug (MT) of Key Companies (2015-2020)
Table 18. Global Narcolepsy Drug Sales Share by Company (2015-2020)
Table 19. Global Narcolepsy Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Narcolepsy Drug Revenue Share by Company (2015-2020)
Table 21. Global Narcolepsy Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Drug as of 2019)
Table 22. Global Narcolepsy Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Narcolepsy Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Narcolepsy Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Narcolepsy Drug Players
Table 27. Global Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 28. Global Narcolepsy Drug Sales Share by Type (2015-2020)
Table 29. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Narcolepsy Drug Price (MT) by Type (2015-2020)
Table 31. Global Narcolepsy Drug Sales Share by Type (2021-2026)
Table 32. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Narcolepsy Drug Revenue Share by Type (2021-2026)
Table 34. Global Narcolepsy Drug Price (MT) by Type (2021-2026)
Table 35. Global Narcolepsy Drug Sales (MT) by Application (2015-2020)
Table 36. Global Narcolepsy Drug Sales Share by Application (2015-2020)
Table 37. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Narcolepsy Drug Price (MT) by Application (2015-2020)
Table 39. Global Narcolepsy Drug Sales (MT) by Application (2021-2026)
Table 40. Global Narcolepsy Drug Sales Share by Application (2021-2026)
Table 41. Global Narcolepsy Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Narcolepsy Drug Revenue Share by Application (2021-2026)
Table 43. Global Narcolepsy Drug Price (MT) by Application (2021-2026)
Table 44. United States Narcolepsy Drug Sales (MT) by Company (2015-2020)
Table 45. United States Narcolepsy Drug Sales Market Share by Company (2015-2020)
Table 46. United States Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 47. United States Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 48. United States Narcolepsy Drug Sales (MT) by Application (2015-2020)
Table 49. United States Narcolepsy Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Narcolepsy Drug Sales (MT) by Company (2015-2020)
Table 51. Europe Narcolepsy Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 53. Europe Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Narcolepsy Drug Sales (MT) by Application (2015-2020)
Table 55. Europe Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 56. China Narcolepsy Drug Sales (MT) by Company (2015-2020)
Table 57. China Narcolepsy Drug Sales Market Share by Company (2015-2020)
Table 58. China Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 59. China Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 60. China Narcolepsy Drug Sales (MT) by Application (2015-2020)
Table 61. China Narcolepsy Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Narcolepsy Drug Sales (MT) by Company (2015-2020)
Table 63. Japan Narcolepsy Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 65. Japan Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Narcolepsy Drug Sales (MT) by Application (2015-2020)
Table 67. Japan Narcolepsy Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Narcolepsy Drug Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Narcolepsy Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Narcolepsy Drug Sales Market Share by Application (2015-2020)
Table 74. India Narcolepsy Drug Sales (MT) by Company (2015-2020)
Table 75. India Narcolepsy Drug Sales Market Share by Company (2015-2020)
Table 76. India Narcolepsy Drug Sales (MT) by Type (2015-2020)
Table 77. India Narcolepsy Drug Sales Market Share by Type (2015-2020)
Table 78. India Narcolepsy Drug Sales (MT) by Application (2015-2020)
Table 79. India Narcolepsy Drug Sales Market Share by Application (2015-2020)
Table 80. Jazz Pharmaceuticals Corporation Information
Table 81. Jazz Pharmaceuticals Description and Business Overview
Table 82. Jazz Pharmaceuticals Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Jazz Pharmaceuticals Narcolepsy Drug Product
Table 84. Jazz Pharmaceuticals Recent Development
Table 85. Teva Pharmaceutical Corporation Information
Table 86. Teva Pharmaceutical Description and Business Overview
Table 87. Teva Pharmaceutical Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceutical Narcolepsy Drug Product
Table 89. Teva Pharmaceutical Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Novartis Narcolepsy Drug Product
Table 94. Novartis Recent Development
Table . Mylan Corporation Information
Table . Mylan Description and Business Overview
Table . Mylan Narcolepsy Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Mylan Narcolepsy Drug Product
Table . Mylan Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Narcolepsy Drug Distributors List
Table 103. Narcolepsy Drug Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Narcolepsy Drug Product Picture
Figure 2. Global Narcolepsy Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Narcolepsy Drug Market Share by Application in 2020 & 2026
Figure 6. Daytime Extreme Sleepiness Examples
Figure 7. Cataplexia Examples
Figure 8. Others Examples
Figure 9. Global Narcolepsy Drug Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Narcolepsy Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Narcolepsy Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Narcolepsy Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Narcolepsy Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Narcolepsy Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Narcolepsy Drug Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Narcolepsy Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Narcolepsy Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Narcolepsy Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Narcolepsy Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Narcolepsy Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Narcolepsy Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Narcolepsy Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Narcolepsy Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Narcolepsy Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Narcolepsy Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Narcolepsy Drug Players Market Share by Revenue in Narcolepsy Drug 2015 & 2019
Figure 27. Narcolepsy Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Narcolepsy Drug Revenue Share by Type (2015-2020)
Figure 29. Global Narcolepsy Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Narcolepsy Drug Revenue Share by Application (2015-2020)
Figure 31. Global Narcolepsy Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Narcolepsy Drug Sales Market Share by Type in 2019
Figure 33. United States Narcolepsy Drug Sales Market Share by Type in 2019
Figure 34. Europe Narcolepsy Drug Sales Market Share by Company in 2019
Figure 35. Europe Narcolepsy Drug Sales Market Share by Type in 2019
Figure 36. Europe Narcolepsy Drug Sales Market Share by Application in 2019
Figure 37. China Narcolepsy Drug Sales Market Share by Company in 2019
Figure 38. China Narcolepsy Drug Sales Market Share by Type in 2019
Figure 39. China Narcolepsy Drug Sales Market Share by Application in 2019
Figure 40. Japan Narcolepsy Drug Sales Market Share by Company in 2019
Figure 41. Japan Narcolepsy Drug Sales Market Share by Type in 2019
Figure 42. Japan Narcolepsy Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Narcolepsy Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Narcolepsy Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Narcolepsy Drug Sales Market Share by Application in 2019
Figure 46. India Narcolepsy Drug Sales Market Share by Company in 2019
Figure 47. India Narcolepsy Drug Sales Market Share by Type in 2019
Figure 48. India Narcolepsy Drug Sales Market Share by Application in 2019
Figure 49. Jazz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Narcolepsy Drug
Figure 55. Manufacturing Process Analysis of Narcolepsy Drug
Figure 56. Narcolepsy Drug Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…
- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 細菌性赤痢薬の世界市場レポート2020 Market Analysis and Insights: Global Bacillary Dysentery Drug Market The global Bacillary Dysentery Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Bacillary Dysentery Drug Scope and Market Size The …